Market Closed -
Warsaw S.E.
11:55:42 2024-05-02 am EDT
|
5-day change
|
1st Jan Change
|
101.8
PLN
|
+0.20%
|
|
+0.79%
|
+6.15%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
970.8
|
1,028
|
1,819
|
1,904
|
2,021
|
-
|
-
|
Enterprise Value (EV)
1 |
1,719
|
1,663
|
1,819
|
2,213
|
2,554
|
2,493
|
2,632
|
P/E ratio
|
10.4
x
|
-
|
4.36
x
|
7.11
x
|
41.7
x
|
12.4
x
|
-
|
Yield
|
6.97%
|
7.08%
|
-
|
22.5%
|
3.68%
|
5.16%
|
-
|
Capitalization / Revenue
|
0.65
x
|
0.7
x
|
-
|
0.8
x
|
0.87
x
|
0.79
x
|
0.83
x
|
EV / Revenue
|
1.15
x
|
1.13
x
|
-
|
0.93
x
|
1.09
x
|
0.98
x
|
1.08
x
|
EV / EBITDA
|
5.94
x
|
5.01
x
|
-
|
4.27
x
|
8.75
x
|
5.43
x
|
5.77
x
|
EV / FCF
|
22.4
x
|
8.51
x
|
-
|
7.48
x
|
94.1
x
|
17.2
x
|
15.1
x
|
FCF Yield
|
4.47%
|
11.7%
|
-
|
13.4%
|
1.06%
|
5.8%
|
6.61%
|
Price to Book
|
-
|
1.31
x
|
-
|
-
|
-
|
-
|
-
|
Nbr of stocks (in thousands)
|
19,853
|
19,853
|
19,853
|
19,853
|
19,853
|
-
|
-
|
Reference price
2 |
48.90
|
51.80
|
91.60
|
95.90
|
101.8
|
101.8
|
101.8
|
Announcement Date
|
3/19/20
|
3/16/21
|
3/16/22
|
3/20/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
1,492
|
1,476
|
-
|
2,388
|
2,334
|
2,547
|
2,441
|
EBITDA
1 |
289.7
|
332.1
|
-
|
518.6
|
292
|
459
|
456
|
EBIT
1 |
173.6
|
179.7
|
-
|
342.9
|
92
|
253.7
|
243
|
Operating Margin
|
11.64%
|
12.17%
|
-
|
14.36%
|
3.94%
|
9.96%
|
9.95%
|
Earnings before Tax (EBT)
1 |
-
|
-
|
-
|
315.5
|
58
|
197
|
209
|
Net income
1 |
93.26
|
117.4
|
417.3
|
267.8
|
48
|
179.4
|
174
|
Net margin
|
6.25%
|
7.96%
|
-
|
11.22%
|
2.06%
|
7.04%
|
7.13%
|
EPS
2 |
4.700
|
-
|
21.02
|
13.49
|
2.440
|
8.230
|
-
|
Free Cash Flow
1 |
76.88
|
195.4
|
-
|
295.8
|
27.15
|
144.6
|
174
|
FCF margin
|
5.15%
|
13.24%
|
-
|
12.38%
|
1.16%
|
5.67%
|
7.13%
|
FCF Conversion (EBITDA)
|
26.54%
|
58.82%
|
-
|
57.04%
|
9.3%
|
31.49%
|
38.16%
|
FCF Conversion (Net income)
|
82.43%
|
166.39%
|
-
|
110.43%
|
56.56%
|
80.57%
|
100%
|
Dividend per Share
2 |
3.410
|
3.670
|
-
|
21.57
|
3.750
|
5.250
|
-
|
Announcement Date
|
3/19/20
|
3/16/21
|
3/16/22
|
3/20/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
749
|
635
|
-
|
309
|
533
|
472
|
611
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
2.584
x
|
1.911
x
|
-
|
0.5954
x
|
1.825
x
|
1.028
x
|
1.339
x
|
Free Cash Flow
1 |
76.9
|
195
|
-
|
296
|
27.2
|
145
|
174
|
ROE (net income / shareholders' equity)
|
-
|
-
|
-
|
19.4%
|
3.8%
|
13%
|
13.7%
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Assets
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
|
-
|
39.60
|
-
|
-
|
-
|
-
|
-
|
Cash Flow per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex
1 |
-
|
170
|
-
|
216
|
228
|
228
|
250
|
Capex / Sales
|
-
|
11.53%
|
-
|
9.06%
|
9.75%
|
8.93%
|
10.24%
|
Announcement Date
|
3/19/20
|
3/16/21
|
3/16/22
|
3/20/24
|
-
|
-
|
-
|
Last Close Price
101.8
PLN Average target price
100.4
PLN Spread / Average Target -1.38% Consensus |
1st Jan change
|
Capi.
|
---|
| +6.15% | 503M | | +14.70% | 65.04B | | -1.61% | 47.76B | | +14.58% | 40.72B | | +20.84% | 26.88B | | +1.16% | 17.53B | | -21.87% | 16.03B | | +1.11% | 15.17B | | -11.34% | 15.06B | | -20.82% | 13.62B |
Other Specialty Chemicals
|